BLA is trading under the 2010’s IPO price This is just the another absurd thing. BLA (Bangkok Life Assurance) is a decent company with consistent operating profits (2-3 Baht per share/year). It is now trading at 12 Baht! The price is at 46% of the book value! ( It was trading at the high of about 300% of the book value back in 2015) And, it is trading at the P/E of 4.67! It is a big company. So the price movement was mostly driven by Institutions and Big Foreign Investors. Although this is a very discounted price, I suggest buying it when the Foreign Investors and institutions stop selling and start accumulating stocks again would be a better buying point. One thing I don’t like about this stock is that it is a very volatile stock. The price is very choppy. The trend, personally, is hard for me to spot and trade. Good mid-term swing trader would like BLA.
BLA
FDA Discussion Update on HistogenicsIn the HSGX longs community (i.e. Stocktwits) it is expected that there will be another update by the company CEO Adam Grizley by the end of year. As there haven't been any updates on the FDA discussions concerning BLA submission since 11-29-2018. The product NeoCart failed phase 3 because it didn't meet Histogenics criteria, not the FDA's. While the FDA continue to go over the data Histogenics stands by with a steady gain in SP.
Go long, go strong, or go home. I'm in for the ride through 2019. Maybe compounding in the dips along the way. Gonna be a great ride!